Gut Biofactory—Neurocompetent Metabolites within the Gastrointestinal Tract. A Scoping Review

• Main Authors: Karolina Skonieczna-Żydecka, Karolina Jakubczyk, Dominika Maciejewska-Markiewicz, Katarzyna Janda, Karolina Kaźmierczak-Siedlecka, Mariusz Kaczmarczyk, Igor Łoniewski, and Wojciech Marlicz
• Format: Article
• Language: English
• Published: MDPI AG 2020-11-01
• Series: Nutrients
• Subjects: microbiome; tryptophan; neurotransmitters; short chain fatty acids; brain
• Online Access: https://www.mdpi.com/2072-6643/12/11/3369

The gut microbiota have gained much scientific attention recently. Apart from unravelling the taxonomic data, we should understand how the altered microbiota structure corresponds to functions of this complex ecosystem. The metabolites of intestinal microorganisms, especially bacteria, exert pleiotropic effects on the human organism and contribute to the host systemic balance. These molecules play key roles in regulating immune and metabolic processes. A subset of them affect the gut brain axis signaling and balance the mental wellbeing. Neurotransmitters, short chain fatty acids, tryptophan catabolites, bile acids and phosphatidylcholine, choline, serotonin, and <i>L</i>-carnitine metabolites possess high neuroactive potential. A scoping literature search in PubMed/Embase was conducted up until 20 June 2020, using three major search terms “microbiota metabolites” AND “gut brain axis” AND “mental health”. This review aimed to enhance our knowledge regarding the gut microbiota functional capacity, and support current and future attempts to create new compounds for future clinical interventions.